Cardiff Oncology
CRDF
66 hedge funds and large institutions have $88.7M invested in Cardiff Oncology in 2015 Q2 according to their latest regulatory filings, with 38 funds opening new positions, 20 increasing their positions, 5 reducing their positions, and 8 closing their positions.
375% more first-time investments, than exits
New positions opened: 38 | Existing positions closed: 8
300% more repeat investments, than reductions
Existing positions increased: 20 | Existing positions reduced: 5
93% more capital invested
Capital invested by funds: $45.8M → $88.7M (+$42.8M)
83% more funds holding
Funds holding: 36 → 66 (+30)
69% less call options, than puts
Call options by funds: $407K | Put options by funds: $1.33M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BFA
BlackRock Fund Advisors
San Francisco,
California
|
+$5.72M |
| 2 |
Goldman Sachs
New York
|
+$3.05M |
| 3 |
BM
Bridger Management
New York
|
+$2.96M |
| 4 |
EI
EAM Investors
Solana Beach,
California
|
+$2.86M |
| 5 |
State Street
Boston,
Massachusetts
|
+$1.86M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
TCM
Tekla Capital Management
Boston,
Massachusetts
|
-$4.43M |
| 2 |
RCM
RA Capital Management
Boston,
Massachusetts
|
-$4.05M |
| 3 |
ACA
Avoro Capital Advisors
New York
|
-$2.21M |
| 4 |
DADC
D.A. Davidson & Co
Great Falls,
Montana
|
-$1.16M |
| 5 |
UBS Group
Zurich,
Switzerland
|
-$334K |
CRDF Hedge Fund Activity: Q2 2015 in Review
66 of the 3,730 institutional investors tracked by Wall St. Rank reported a position in Cardiff Oncology (CRDF) for Q2 2015, worth a combined $88.7M — up 93% from $45.8M a quarter earlier.
Buyers outnumbered sellers: 38 funds opened new CRDF positions and 8 closed out — a net gain of 30 holders — while 20 added to existing stakes and 5 trimmed.
The largest buyer was BlackRock Fund Advisors, adding an estimated $5.72M. The largest seller was Tekla Capital Management, exiting entirely with an estimated $4.43M sold.
- 66 institutional investors held Cardiff Oncology (CRDF) as of Q2 2015, up from 36 in Q1 2015.
- Funds reported $88.7M of Cardiff Oncology stock for Q2 2015, up 93% quarter-over-quarter.
- 38 funds opened new Cardiff Oncology positions in Q2 2015 and 8 closed out, a net change of +30 holders.
- The largest Cardiff Oncology buyer in Q2 2015 was BlackRock Fund Advisors, an estimated $5.72M added.
- The largest Cardiff Oncology seller in Q2 2015 was Tekla Capital Management, an estimated $4.43M sold.
Based on aggregated 13F filings for Q2 2015.